MARKET

OCUTF

OCUTF

Ocumension Thera
OTCPK
--
NaN%
Closed 09:30 03/27 EDT
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
EyePoint Pharmaceuticals Director sells stock worth $37M
EyePoint Pharmaceuticals Director sells stock worth $37M on Jan. 11. Ye Liu sold 1.9M shares at $19.45 per share. The stock price is marginally down 0.26% on Wednesday during pre-market trading. The shares are held by Ocumension Therapeutics.
Seeking Alpha · 01/17 11:00
About OCUTF
Ocumension Therapeutics is a China-based holding company principally involved in the discovering, developing and commercializing ophthalmic therapies. Its main products include OT-401 (YUTIQ), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-301 (NCX 470), OT-101 and OT-202, among others. The Company conducts its businesses in the domestic market.

Webull offers Ocumension Therapeutics stock information, including OTCPK: OCUTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCUTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCUTF stock methods without spending real money on the virtual paper trading platform.